Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-05-15
2007-05-15
Chism, B. Dell (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S018700
Reexamination Certificate
active
11186629
ABSTRACT:
The invention provides isolated agents having novel chemical structures and possessing superior activity as derepressors of IAP inhibited caspase. The invention further provides a method of derepressing an IAP-inhibited caspase. The invention further provides assay methods employing labeled compounds of the invention, especially fluorescent labeled compounds.
REFERENCES:
patent: 4631211 (1986-12-01), Houghten
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5556762 (1996-09-01), Pinilla et al.
patent: 5766848 (1998-06-01), Borden et al.
patent: 6159709 (2000-12-01), Korneluk et al.
patent: 6228603 (2001-05-01), Reed et al.
patent: 6911426 (2005-06-01), Reed et al.
patent: 2003/0180805 (2003-09-01), Reed et al.
patent: 2005/0119176 (2005-06-01), Reed et al.
patent: WO 92/09300 (1992-06-01), None
Ambrosini et al., “A novel anti-apoptosis gene,survivin, expressed in cancer and lymphoma,”Nature Med.3:917-921 (1997).
Bertin et al., “Apoptotic suppression by baculovirus P35 involves cleavage by and inhibition of a virus-induced CED-3/ICE-like protease,”J.Virol70:6251-6259 (1996).
Birnbaum et al., “An Apoptosis-inhibiting Gene from a Nuclear Polyhedrosis Virus Encoding a Polypeptide with Cys/His Sequence Motifs,”J. Virol.68:2521-2528 (1994).
Boldin et al., “Involvement of MACH, a Novel MORT1/FADD-Interacting Protease, in Fas/APO-1- and TNF Receptor-Induced Cell Death,”Cell85:803-815 (1996).
Bump et al., “Inhibition of ICE Family Proteases by Baculovirus Antiapoptotic protein p35,”Science269:1885-1888 (1995).
Casciola-Rosen et al., “Apopain/CPP32 Cleaves Proteins That Are Essential for Cellular Repair: A Fundamental Principle of Apoptotic Death,”J. Exp. Med.183:1957-1964 (1996).
Chai et al., “Structural and biochemical basis of apoptotic activation by Smac/DIABLO,”Nature406:855-862 (2000).
Chen et al., “A Human IAP-Family Gene,Apollon, Expressed in Human Brain Cancer Cells,”Biochem. Biophys. Res. Commun.264:847-854 (1999).
Deveraux et al., “IAPs block apoptotic events induced by caspase-8 and cytochromecby direct inhibition of distinct caspases,”EMBO J.17:2215-2223 (1998).
Deveraux et al., “X-linked IAP is a direct inhibitor of cell-deaht proteases,”Nature388:300-304 (1997).
Deveraux and Reed, “IAP family proteins—suppressors of apoptosis,”Genes and Development13:239-252 (1999).
Dooley et al., “An All D-Amino Acid Opioid Peptide with Central Analgesic Activity from a Combinatorial Library,”Science266:2019-2022 (1994).
Du et al., “Smac, a Mitochondrial Protein that Promotes Cytochrome c-Dependent Caspase Activation by Eliminating IAP Inhibition,”Cell102:33-42 (2000).
Hawkins, et al. “Inhibition of interleukin 1β-converting enzyme-mediated apoptosis of mammalian cells by baculovirus IAP,”Proc. Nat'l Acad.Sci. USA 93:13786-13790 (1996).
Houghten et al., “Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery,”Nature354:84-86 (1991).
Kasof and Gomes, “Livin, a Novel Inhibitor of Apoptosis Protein Family Member,”J. Biol. Chem.276:3238-3246 (2001).
Kharbanda et al., “Role for Bcl-xLas an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis,”Proc. Natl. Acad. Sci. USA94:6939-6942 (1997).
Kluck et al., “The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis,”Science275:1132-1136 (1997).
Li et al., “Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade,”Cell91:479-489 (1997).
Liston et al., “Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes,”Nature379:349-353 (1996).
Liu et al., “Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c,”Cell86:147-157 (1996).
Liu et al., “DFF, a Heterodimeric Protein That Functions Downstream of Caspase-3 to Trigger DNA Fragmentation during Apoptosis,”Cell89:175-184 (1997).
Liu et al., “Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain,”Nature408:1004-1008 (2000).
Martin and Green, “Protease Activation during Apoptosis: Death by a Thousand Cuts?”Cell82:349-352 (1995).
Muzio et al., “FLICE, a Novel FADD-Homologous ICE/CED-3-like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex,”Cell85:817-827 (1996).
Reed and Tomaselli, “Drug discovery opportunities from apoptosis research,”Cur. Opin. Biotech.11:586-592 (2000).
Reed, “Apoptosis-regulating proteins as targets for drug discovery,”Trends Mol. Med.7:314-319 (2001).
Riedl et al., “Structural Basis for the Inhibition of Caspase-3 by XIAP,”Cell104:791-800 (2001).
Rothe et al., “The TNFR2-TRAF Signaling Complex Contains Two Novel Proteins Related to Baculoviral Inhibitor of Apoptosis Proteins,”Cell83:1243-1252 (1995).
Roy et al., “The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases,”EMBO J.16:6914-6925 (1997).
Sun et al., “NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP,”Nature401:818-822 (1999).
Srinivasula et al., “Molecular Determinants of the Caspase-promoting Activity of Smac/DIABLO and Its Role in the Death Receptor Pathway,”J. Bio. Chem.275:36152-36157 (2000).
Srinivasula et al., “A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis,”Nature410:112-116 (2001).
Takahashi et al., “Cleavage of lamin A by Mch2α but not CPP32: Multiple interleukin 1β-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis,”Proc. Natl. Acad. Sci. USA93:8395-8400 (1996).
Takahashi et al., A Single BIR Domain of XIAP Sufficient for Inhibiting Caspases,J. Biol. Chem.273:7787-7790 (1998).
Verhagen et al., “Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP Proteins,”Cell102:43-53 (2000).
Villa et al. “Caspases and caspase inhibitors,”TIBS.22:388-393 (1997).
Vucic et al., “ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas,”Cur. Biol.10:1359-1366 (2000).
Wang et al., “Cleavage of sterol regulatory element binding proteins (SREBPs) by CPP32 during apoptosis,”EMBO J.15:1012-1020 (1996).
Wu et al., “Structural basis of IAP recognition by Smac/DIABLO,”Nature408:1008-1012 (2000).
Yang et al., “Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked,”Science 275:1129-1132 (1997).
Zhou et al., “Target Protease Specificity of the Viral Serpin CrmA. Analysis of Five Caspases,”J. Biol. Chem.272:7797-7800 (1997).
Zhou et al., “IL-10 Inhibits Apoptosis of Promyeloid Cells by Activating Insulin Receptor Substrate-2 and Phosphatidylinositol 3′- Kinase,”J. Immunol.167:4436-4442 (2001).
Zou et al., “Apaf-1, a Human Protein Homologous toC. elegansCED-4, Participates in Cytochrome c-Dependent Activation of Caspase-3,” Cell 90:405-413 (1997).
Nefzi et al., “An efficient two-step synthesis of mono-, di- and triureas from resin bound amides,” Tetrahedron Lett., 41:5441-5446 (2000).
Houghten Richard A.
Nefzi Adel
Ostresh John M.
Pinilla Clemencia
Reed John C.
Chism B. Dell
Khanna Hemant
McDermott Will & Emery LLP
The Burnham Institute
Torrey Pines Institute for Molecular Studies
LandOfFree
Methods and compositions for derepression of IAP-inhibited... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for derepression of IAP-inhibited..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for derepression of IAP-inhibited... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3754920